nach oben

Erschienen in:

01.03.2008 | Experimental

Chronic Escherichia coli infection induces muscle wasting without changing acetylcholine receptor numbers

verfasst von: Christiane G. Frick, Heidrun Fink, Maria L. Gordan, Barbara Eckel, J. A. Jeevendra Martyn, Manfred Blobner

Erschienen in: Intensive Care Medicine | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Abstract

Objective

Muscle weakness in septic patients is a serious problem as it complicates and lengthens hospital stays, prolongs rehabilitation and increases costs. We examined the effects of a chronic infection with Escherichia coli on muscle function, muscle mass, and the expression of nicotinic acetylcholine receptors (AChRs).

Design and setting

Prospective, randomized animal study in an animal laboratory, university hospital.

Subjects

Sprague-Dawley rats.

Interventions

A catheter was implanted into the external jugular vein of anesthetized rats, and a dose of 3.2 × 10⁸ CFU of E. coli bacteria was injected; the catheter was then sealed and tunneled subcutaneously.

Measurements and results

Animals injected with E. coli bacteria showed a significant decrease in body and muscle mass over the 14-day experimental period. Neuromuscular function was tested by mechanomyography on days 3, 7, and 14 following injection. Tetanic tension decreased over the time course of sepsis, without effecting tetanic fade. Serum levels of acute-phase protein, α₁-acid glycoprotein, were increased by day 3, and remained significantly higher until day 14. AChRs were quantitated using ¹²⁵I-labeled bungarotoxin and revealed no differences between groups.

Conclusions

Central venous injection of E. coli bacteria induces systemic inflammation evidenced as loss of body weight, muscle mass and increased α₁-acid glycoprotein levels. The inflammation-induced muscle weakness is due to muscle atrophy and not to upregulated AChRs. This model may prove useful for studying maneuvers to prevent muscle wasting with inflammation.

Bolton CF (2005) Neuromuscular manifestations of critical illness. Muscle Nerve 32:140–163PubMedCrossRef

Zochodne DW, Bolton CF (1996) Neuromuscular disorders in critical illness. Baillieres Clin Neurol 5:645–671PubMed

Bolton CF (1993) Neuromuscular complications of sepsis. Intensive Care Med Suppl 19(2):S58–S63CrossRef

Bednarík J, Vondracek P, Dusek L, Moravcova E, Cundrle I (2005) Risk factors for critical illness polyneuromyopathy. J Neurol 252:343–351PubMedCrossRef

Johnson KL (2007) Neuromuscular complications in the intensive care unit: critical illness polyneuromyopathy. AACN Adv Crit Care 18:167–180PubMed

Rannou F, Pennec JP, Rossignol B, Morel J, Dorange G, Arvieux C, Gioux M, Giroux-Metges MA (2007) Effects of chronic sepsis on rat motor units: experimental study of critical illness polyneuromyopathy. Exp Neurol 204:741–747PubMedCrossRef

De Letter MA, Schmitz PI, Visser LH, Verheul FA, Schellens RL, Op de Coul DA, van der Meche FG (2001) Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit Care Med 29:2281–2286PubMedCrossRef

De Jonghe B, Sharshar T, Lefaucheur JP, Authier FJ, Durand-Zaleski I, Boussarsar M, Cerf C, Renaud E, Mesrati F, Carlet J, Raphael JC, Outin H, Bastuji-Garin S (2002) Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 288:2859–2867PubMedCrossRef

Hund E (2001) Neurological complications of sepsis: critical illness polyneuropathy and myopathy. J Neurol 248:929–934PubMedCrossRef

10.

Fletcher SN, Kennedy DD, Ghosh IR, Misra VP, Kiff K, Coakley JH, Hinds CJ (2003) Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness. Crit Care Med 31:1012–1016PubMedCrossRef

11.

Visser LH (2006) Critical Illness polyneuropathy and myopathy: clinical features, risk factors and prognosis. Eur J Neurol 13:1203–1212PubMedCrossRef

12.

Bolton CF (1996) Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. Crit Care Med 24:1408–1416PubMedCrossRef

13.

Sieck GC, Prakash YS (1995) Fatigue at the neuromuscular junction. Branch point vs. presynaptic vs. postsynaptic mechanisms. Adv Exp Med Biol 384:83–100PubMed

14.

Coakley JH, Nagendran K, Hanover M (1993) Neuromuscular abnormalities in the critical ill. Intensive Care Med 19:323–328PubMedCrossRef

15.

Ibebunjo C, Martyn JA (1999) Fiber atrophy, but not changes in acetylcholine receptor expression, contributes to the muscle dysfunction after immobilization. Crit Care Med 27:275–285PubMedCrossRef

16.

Breuille D, Voisin L, Contrepois M, Arnal M, Rose F, Obled C (1999) A sustained rat model for studying the long-lasting catabolic state of sepsis. Infect Immun 67:1079–1085PubMed

17.

Fink MP, Heard SO (1990) Laboratory models of sepsis and septic shock. J Surg Res 49:186–196PubMedCrossRef

18.

Wichterman KA, Baue AE, Chaudry IH (1980) Sepsis and septic shock–a review of laboratory models and a proposal. J Surg Res 29:189–201PubMedCrossRef

19.

Metzger J, Blobner M, Luppa PB (2001) Sensitive chemiluminescence immunoassay for the determination of rat serum alpha1-acid glycoprotein. Clin Chem Lab Med 39:514–518PubMedCrossRef

20.

Breuille D, Rose F, Arnal M, Melin C, Obled C (1994) Sepsis modifies the contribution of different organs to whole-body protein synthesis in rats. Clin Sci (Lond) 86:663–669

21.

Andrews P, Azoulay E, Antonelli M, Brochard L, Brun-Buisson C, De Backer D, Dobb G, Fagon JY, Gerlach H, Groeneveld J, Macrae D, Mancebo J, Metnitz P, Nava S, Pugin J, Pinsky M, Radermacher P, Richard C (2005) Year in review in intensive care medicine. I. Experimental studies. Clinical studies: brain injury, renal failure and endocrinology. Intensive Care Med 33:49–57CrossRef

22.

Fink H, Luppa P, Mayer B, Rosenbrock H, Metzger J, Martyn JA, Blobner M (2003) Systemic inflammation leads to resistance to atracurium without increasing membrane expression of acetylcholine receptors. Anesthesiology 98:82–88PubMedCrossRef

23.

Cooney RN, Kimball SR, Vary TC (1997) Regulation of skeletal muscle protein turnover during sepsis: mechanisms and mediators. Shock 7:1–16PubMedCrossRef

24.

Voisin L, Breuille D, Combaret L, Pouyet C, Taillandier D, Aurousseau E, Obled C, Attaix D (1996) Muscle wasting in a rat model of long-lasting sepsis results from the activation of lysosomal, Ca2+-activated, and ubiquitin-proteasome proteolytic pathways. J Clin Invest 97:1610–1617PubMedCrossRef

25.

Rennie MJ, Edwards RH, Emery PW, Halliday D, Lundholm K, Millward DJ (1983) Depressed protein synthesis is the dominant characteristic of muscle wasting and cachexia. Clin Physiol 3:387–398PubMed

26.

Vary TC, Kimball SR (1992) Regulation of hepatic protein synthesis in chronic inflammation and sepsis. Am J Physiol 262:C445–C452PubMed

27.

Clowes GH Jr, George BC, Villee CA Jr, Saravis CA (1983) Muscle proteolysis induced by a circulating peptide in patients with sepsis or trauma. N Engl J Med 308:545–552PubMedCrossRef

28.

Hasselgren PO, Talamini M, James JH, Fischer JE (1986) Protein metabolism in different types of skeletal muscle during early and late sepsis in rats. Arch Surg 121:918–923PubMed

29.

Ibebunjo C, Martyn J (2001) Disparate dysfunction of skeletal muscles located near and distant from burn site in the rat. Muscle Nerve 24:1283–1294PubMedCrossRef

30.

Blobner M, Kochs E, Fink H, Mayer B, Veihelmann A, Brill T, Stadler J (1999) Pharmacokinetics and pharmacodynamics of vecuronium in rats with systemic inflammatory response syndrome: treatment with NG-monomethyl-L-arginine. Anesthesiology 91:999–1005PubMedCrossRef

31.

Martyn JA, White DA, Gronert GA, Jaffe RS, Ward JM (1992) Up-and-down regulation of skeletal muscle acetylcholine receptors. Effects on neuromuscular blockers. Anesthesiology 76:822–843PubMedCrossRef

32.

Tomera JF, Martyn J (1989) Intraperitoneal endotoxin but not protein malnutrition shifts d-tubocurarine dose-response curves in mouse gastrocnemius muscle. J Pharmacol Exp Ther 250:216–220PubMed

33.

Martyn JA, Richtsfeld M (2006) Succinylcholine-induced hyperkalemia in acquired pathologic states: etiologic factors and molecular mechanisms. Anesthesiology 104:158–169PubMedCrossRef

34.

Vincent A, Newland C, Croxen R, Beeson D (1997) Genes at the junction-candidates for congenital myasthenic syndromes. Trends Neurosci 20:15–22PubMedCrossRef

35.

Kohlschutter B, Baur H, Roth F (1976) Suxamethonium-induced hyperkalaemia in patients with severe intra-abdominal infections. Br J Anaesth 48:557–562PubMedCrossRef

36.

Gronert GA (1999) Succinylcholine hyperkalemia after burns. Anesthesiology 91:320–322PubMedCrossRef

37.

Tsukagoshi H, Morita T, Takahashi K, Kunimoto F, Goto F (1999) Cecal ligation and puncture peritonitis model shows decreased nicotinic acetylcholine receptor numbers in rat muscle: immunopathologic mechanisms? Anesthesiology 91:448–460PubMedCrossRef

Titel: Chronic Escherichia coli infection induces muscle wasting without changing acetylcholine receptor numbers
verfasst von: Christiane G. Frick
Heidrun Fink
Maria L. Gordan
Barbara Eckel
J. A. Jeevendra Martyn
Manfred Blobner
Publikationsdatum: 01.03.2008
Verlag: Springer-Verlag
Erschienen in: Intensive Care Medicine / Ausgabe 3/2008
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-007-0852-3

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren

Springer Medizin

Chronic Escherichia coli infection induces muscle wasting without changing acetylcholine receptor numbers